Circulating glycocalyx biomarkers in the acute phase and long-term follow-up in patients with Kawasaki disease

Microvasc Res. 2023 May:147:104507. doi: 10.1016/j.mvr.2023.104507. Epub 2023 Feb 18.

Authors

André Jakob¹, Claudia Nussbaum², Belén Pastor-Villaescusa³

Affiliations

¹ Ludwig-Maximilians-University of Munich, Department of Pediatric Cardiology, Marchioninistr. 15, 81377 Munich, Germany. Electronic address: andre.jakob@med.uni-muenchen.de.
² Div. of Neoantology, Dr. von Hauner Children's Hospital, LMU Munich, 80337 Munich, Germany.
³ Ludwig-Maximilians-University of Munich, Department of Pediatric Cardiology, Marchioninistr. 15, 81377 Munich, Germany.

PMID: 36804181
DOI: 10.1016/j.mvr.2023.104507

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Follow-Up Studies
Glycocalyx
Humans
Mucocutaneous Lymph Node Syndrome*

Substances

Biomarkers